{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:02:31Z","timestamp":1760346151185},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPAA"],"DOI":"10.2147\/cpaa.s10929","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T04:00:23Z","timestamp":1284955223000},"page":"135","source":"Crossref","is-referenced-by-count":2,"title":["Rituximab in severe skin diseases: target, disease, and dose"],"prefix":"10.2147","author":[{"family":"Cable","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,7]]},"container-title":["Clinical Pharmacology: Advances and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=6775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:05:08Z","timestamp":1477865108000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/rituximab-in-severe-skin-diseases-target-disease-and-dose-peer-reviewed-article-CPAA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cpaa.s10929","relation":{},"ISSN":["1179-1438"],"issn-type":[{"value":"1179-1438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}